Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $67.4 million.

  • Abivax's Shares Outstanding (Diluted Average) rose 5.98% to $71.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.8 million, marking a year-over-year increase of 5.98%. This contributed to the annual value of $67.4 million for FY2024, which is 45.40% up from last year.
  • According to the latest figures from FY2024, Abivax's Shares Outstanding (Diluted Average) is $67.4 million, which was up 45.40% from $46.3 million recorded in FY2023.
  • Abivax's 5-year Shares Outstanding (Diluted Average) high stood at $67.4 million for FY2024, and its period low was $18.3 million during FY2021.
  • In the last 3 years, Abivax's Shares Outstanding (Diluted Average) had a median value of $46.3 million in 2023 and averaged $44.6 million.
  • Data for Abivax's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 130.27% (in 2023) over the last 5 years.
  • Over the past 4 years, Abivax's Shares Outstanding (Diluted Average) (Yearly) stood at $18.3 million in 2021, then grew by 10.02% to $20.1 million in 2022, then skyrocketed by 130.27% to $46.3 million in 2023, then surged by 45.40% to $67.4 million in 2024.